Macmic Science&Technology Co.,Ltd. (SHA:688711)
China · Delayed Price · Currency is CNY 33.90
-3.98 (-10.51%)
May 29, 2026, 3:00 PM CST
Macmic Science&Technology Income Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Revenue | 1,359 | 1,334 | 1,327 | 1,487 | 920.83 | 544.51 |
Other Revenue | - | 14.04 | 4.54 | 18.1 | 5.25 | 6.12 |
| 1,359 | 1,348 | 1,331 | 1,505 | 926.08 | 550.64 | |
Revenue Growth (YoY) | -1.68% | 1.23% | -11.52% | 62.48% | 68.18% | 66.04% |
Cost of Revenue | 1,131 | 1,129 | 1,157 | 1,174 | 733.5 | 433.78 |
Gross Profit | 227.77 | 218.87 | 174.75 | 330.67 | 192.59 | 116.85 |
Selling, General & Admin | 96.45 | 97.46 | 85.68 | 84.19 | 54 | 32.88 |
Research & Development | 119.79 | 115.36 | 109.76 | 108.1 | 64.28 | 37.9 |
Other Operating Expenses | -39.15 | -24 | -9.49 | 1.27 | -3.93 | 0.52 |
Operating Expenses | 177.09 | 189.71 | 188.67 | 204.86 | 120.99 | 75.74 |
Operating Income | 50.68 | 29.16 | -13.92 | 125.81 | 71.59 | 41.11 |
Interest Expense | - | -34.42 | -30.2 | -21.18 | -6.61 | -2.96 |
Interest & Investment Income | 6.62 | 7.75 | 16 | 6.78 | 11.31 | 2.55 |
Currency Exchange Gain (Loss) | - | -1.64 | -0.39 | -3.95 | -4.25 | 2.86 |
Other Non Operating Income (Expenses) | -34.07 | -0.16 | -0.92 | -0.4 | -0.14 | -0.37 |
EBT Excluding Unusual Items | 23.23 | 0.69 | -29.43 | 107.06 | 71.9 | 43.19 |
Impairment of Goodwill | - | - | -8.39 | - | - | - |
Gain (Loss) on Sale of Investments | 1.46 | 0.46 | -13.55 | -5.88 | 0.67 | 0.51 |
Gain (Loss) on Sale of Assets | -0.84 | -1 | -0.86 | 4.07 | -0.03 | 0.04 |
Asset Writedown | -15.88 | 0 | 0.02 | - | - | - |
Other Unusual Items | - | 10.6 | 15.67 | 9.75 | 5.32 | 28.57 |
Pretax Income | 7.97 | 10.76 | -36.55 | 114.99 | 77.86 | 72.31 |
Income Tax Expense | -5.32 | -4.53 | -13.61 | 0.78 | -0.68 | 4.07 |
Earnings From Continuing Operations | 13.28 | 15.29 | -22.94 | 114.21 | 78.54 | 68.25 |
Minority Interest in Earnings | 3.66 | 1.83 | 8.47 | 1.99 | 0.17 | 0.58 |
Net Income | 16.94 | 17.11 | -14.47 | 116.19 | 78.71 | 68.83 |
Net Income to Common | 16.94 | 17.11 | -14.47 | 116.19 | 78.71 | 68.83 |
Net Income Growth | - | - | - | 47.63% | 14.35% | 158.39% |
Shares Outstanding (Basic) | 214 | 214 | 207 | 213 | 212 | 177 |
Shares Outstanding (Diluted) | 214 | 214 | 207 | 213 | 213 | 177 |
Shares Change (YoY) | 3.31% | 3.51% | -2.76% | -0.11% | 20.44% | 16.93% |
EPS (Basic) | 0.08 | 0.08 | -0.07 | 0.55 | 0.37 | 0.39 |
EPS (Diluted) | 0.08 | 0.08 | -0.07 | 0.55 | 0.37 | 0.39 |
EPS Growth | - | - | - | 47.80% | -5.06% | 120.99% |
Free Cash Flow | 141.31 | 72.42 | 6.19 | -353.86 | -211.31 | -122.48 |
Free Cash Flow Per Share | 0.66 | 0.34 | 0.03 | -1.67 | -0.99 | -0.69 |
Dividend Per Share | - | - | - | 0.064 | 0.042 | - |
Dividend Growth | - | - | - | 54.57% | - | - |
Gross Margin | 16.76% | 16.24% | 13.13% | 21.98% | 20.80% | 21.22% |
Operating Margin | 3.73% | 2.16% | -1.04% | 8.36% | 7.73% | 7.47% |
Profit Margin | 1.25% | 1.27% | -1.09% | 7.72% | 8.50% | 12.50% |
Free Cash Flow Margin | 10.40% | 5.37% | 0.46% | -23.52% | -22.82% | -22.24% |
EBITDA | 148.44 | 114.58 | 47.59 | 158.17 | 89.93 | 53.69 |
EBITDA Margin | 10.92% | 8.50% | 3.57% | 10.51% | 9.71% | 9.75% |
D&A For EBITDA | 97.76 | 85.42 | 61.51 | 32.36 | 18.34 | 12.58 |
EBIT | 50.68 | 29.16 | -13.92 | 125.81 | 71.59 | 41.11 |
EBIT Margin | 3.73% | 2.16% | -1.04% | 8.36% | 7.73% | 7.47% |
Effective Tax Rate | - | - | - | 0.68% | - | 5.62% |
Revenue as Reported | - | 1,348 | 1,331 | 1,505 | 926.08 | 550.64 |
Advertising Expenses | - | 5.32 | 3.95 | 2.33 | 1.13 | 1.42 |